Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
CANO.WS was delisted on the 9th of November, 2023.
2 hedge funds and large institutions have $279 invested in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 19 closing their positions.
90% less funds holding
Funds holding: 21 → 2 (-19)
100% less capital invested
Capital invested by funds: $722K → $279 (-$721K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 19
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ZA
Zazove Associates
Incline Village,
Nevada
|
-$263K |
| 2 |
Barclays
London,
United Kingdom
|
-$110K |
| 3 |
ICM
Ionic Capital Management
New York
|
-$56K |
| 4 |
BlackRock
New York
|
-$53.4K |
| 5 |
CAC
Cowen and Company
New York
|
-$36.8K |
CANO.WS Hedge Fund Activity: Q4 2023 in Review
2 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) for Q4 2023, worth a combined $279 — down 100% from $722K a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of CANO.WS and 0 opened new positions — a net loss of 19 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Zazove Associates, exiting entirely with an estimated $263K sold.
- 2 institutional investors held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) as of Q4 2023, down from 21 in Q3 2023.
- Funds reported $279 of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 stock for Q4 2023, down 100% quarter-over-quarter.
- 0 funds opened new Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 positions in Q4 2023 and 19 closed out, a net change of -19 holders.
- The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 seller in Q4 2023 was Zazove Associates, an estimated $263K sold.
Based on aggregated 13F filings for Q4 2023.